Pulmonary metastasectomy in sarcoma-experiences with laser-assisted resection.
@article{Schmid2018PulmonaryMI, title={Pulmonary metastasectomy in sarcoma-experiences with laser-assisted resection.}, author={Severin Schmid and Uyen-Thao Le and Christoph Zeisel and Benedikt Haager and Bernward Passlick}, journal={Journal of thoracic disease}, year={2018}, volume={10 1}, pages={ 314-320 } }
Background
Previous data suggest a survival benefit in well selected patients with extrathoracic sarcoma after pulmonary metastasectomy. Different techniques have been described for pulmonary metastasectomy; however laser-assisted surgery (LAS) was suggested to provide the best outcome in patients with higher numbers of metastases.
Methods
Data were extracted from a prospectively maintained institutional database and a total of 83 patients who underwent pulmonary metastasectomy at our clinic…
7 Citations
Results of redo pulmonary metastasectomy
- MedicineJournal of thoracic disease
- 2021
It is stated that redo lung metastasectomy is worthwhile when the lesions are resectable and the perioperative risk is low, and there are no “non-surgical” therapeutic options to replace redo pulmonary metastasectomies.
Is laser-assisted resection preferable to lobectomy for pulmonary metastasectomy?
- MedicineLasers in Medical Science
- 2019
It is believed that laser resection can be proposed as a reliable and advantageous lung-sparing technique, as an alternative to lobectomy for metastasectomy, when stapler wedge resection is not feasible.
Surgical Morbidity and Lung Function Changes After Laser–Assisted Pulmonary Metastasectomy: A Prospective Bicentric Study
- MedicineFrontiers in Surgery
- 2021
LAS is a safe and effective method for PM even for higher numbers of metastases, with short duration of postoperative air leak and little morbidity, including changes of lung function after laser–assisted surgery.
Changes in the surgical treatment of pulmonary metastases during the last 12 years
- MedicineOrvosi hetilap
- 2020
During the last 12 years, there was a more than two-fold increase in the number of patients requiring surgery due to pulmonary metastases, and the ratio of VATS metastasectomy increased significantly as well (5.3% vs. 64.9%).
Local Effects of a 1940 nm Thulium-Doped Fiber Laser and a 1470 nm Diode Laser on the Pulmonary Parenchyma: An Experimental Study in a Pig Model
- MedicineMaterials
- 2021
TDFL caused less thermal damage to the lung parenchyma than DL and the superficial zone of thermal damage was narrower for TDFL on both days 0 and 7, confirming the effectiveness of both types of laser in cutting and providing hemostasis in the lungs.
Local recurrence after laser-assisted pulmonary metastasectomy
- Medicine
- 2022
Patients and methods, study design, inclusion and exclusion criteria, data collection and variables definitions, and statistical analysis are reviewed.
Lung Metastatectomy: Can Laser-Assisted Surgery Make a Difference?
- MedicineCurrent oncology
- 2022
LAS allows radical lung-parenchyma saving resection of a high number of lung metastases with similar survival to conventional methods, and is a safe procedure with a postoperative morbidity up to 24.2% and almost zero mortality.
References
SHOWING 1-10 OF 23 REFERENCES
Pulmonary metastasectomy - A retrospective comparison of surgical outcomes after laser-assisted and conventional resection.
- MedicineEuropean journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
- 2017
[Pulmonary metastasectomy: an analysis of technical and oncological outcomes in 301 patients with a focus on laser resection].
- MedicineZentralblatt fur Chirurgie
- 2013
The number of metastases has an influence on prognosis but seems to be of secondary importance, particularly if complete technical resectability with the aid of the laser is given.
Resection of pulmonary metastases from sarcoma: can some patients benefit from a less invasive approach?
- MedicineThe Annals of thoracic surgery
- 2009
Pulmonary metastasectomy: a multivariate analysis of 440 patients undergoing complete resection.
- MedicineInteractive cardiovascular and thoracic surgery
- 2012
The decision to consider a patient for resection of metastastic disease should include factors beyond the feasibility of complete removal, and the benefit of such an aggressive surgical approach is only limited to selected subgroups of patients.
Pulmonary metastasectomy for osteogenic and soft tissue sarcoma: who really benefits from surgical treatment?
- MedicineEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
- 2013
The survival of those patients with one or two pulmonary nodules and those who underwent complete resection was favourable following the treatment of osteogenic and soft tissue sarcomas with PM, and redo surgery may also provide some survival benefit in patients with poor prognostic factors.
Pulmonary resection of metastatic sarcoma: prognostic factors associated with improved outcomes.
- MedicineThe Annals of thoracic surgery
- 2011
Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases.
- MedicineThe Journal of thoracic and cardiovascular surgery
- 1997
Resection of pulmonary and extrapulmonary sarcomatous metastases is associated with long-term survival.
- MedicineThe Annals of thoracic surgery
- 2009
Pulmonary metastasectomy for sarcoma: a systematic review of reported outcomes in the context of Thames Cancer Registry data
- MedicineBMJ Open
- 2012
The 5 year survival rate among sarcoma patients who are selected to have pulmonary metastasectomy is higher than that observed among unselected registry data for patients with any metastatic disease at diagnosis.
Long-term results after resection for bone sarcoma pulmonary metastases.
- MedicineEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
- 2010